| Candida Ann Theresa Singh, PHARMD | |
|
657 E Main St, Anoka, MN 55303-2528 | |
| (763) 427-2457 | |
| (763) 427-2647 |
| Full Name | Candida Ann Theresa Singh |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 657 E Main St, Anoka, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457980849 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 123183 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Candida Ann Theresa Singh, PHARMD 657 E Main St, Anoka, MN 55303-2528 Ph: (763) 427-2457 | Candida Ann Theresa Singh, PHARMD 657 E Main St, Anoka, MN 55303-2528 Ph: (763) 427-2457 |
News Archive
Cloning, X-chromosome inactivation, stem cells, and embryogenesis are hot areas of research at the moment, and protocols featured in this month's release of Cold Spring Harbor Protocols will aid these studies.
Nitrogen is a basic building block of all the body's proteins, RNA and DNA, so cancerous tumors are greedy for this element. Researchers at the Weizmann Institute of Science, in collaboration with colleagues from the National Cancer Institute and elsewhere, have now shown that in many cancers, the patient's nitrogen metabolism is altered, producing detectable changes in the body fluids and contributing to the emergence of new mutations in cancerous tissue.
Quintiles, the world's leading biopharmaceutical services company, and London Genetics, an expert in the use of pharmacogenetics in drug discovery and development, today announced a strategic alliance to offer the biopharmaceutical industry innovative pharmacogenetics solutions to advance personalized medicine. Financial terms were not disclosed.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the presentation of the latest interim data from a Phase II, multi-center, randomized, dose-ranging clinical trial evaluating the safety and antiviral activity of MK-5172, for the treatment of chronic hepatitis C virus genotype 1 infection.
› Verified 9 days ago
Alexi Johnson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1911 S Ferry St, Anoka, MN 55303 Phone: 763-576-0388 | |
Carisa Lynn Finke, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3301 7th Ave, Anoka, MN 55303 Phone: 651-431-5123 | |
Dr. Heidi Lee Holthus, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3605 Round Lake Blvd Nw, Anoka, MN 55303 Phone: 763-252-0751 | |
Amanda Marie Schroepfer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Jacob Ln, Anoka, MN 55303 Phone: 763-421-5540 Fax: 763-421-9229 | |
Gordon A. Seim, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1100 W Highway 10, Anoka, MN 55303 Phone: 763-427-7699 Fax: 763-712-8314 | |
Emily K Hulke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 601 Jacob Ln, Anoka, MN 55303 Phone: 763-421-5540 | |
Steven Thomas Simenson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Monroe St, Anoka, MN 55303 Phone: 763-421-5540 Fax: 763-421-9229 |